CAR-T for r/r Malignant Tumors in Children

Summary

This study is a clinical study of CAR-T treatment of patients with relapsed/refractory malignant tumors in children. The purpose is to evaluate the safety and effectiveness of chimeric antigen receptor T cells in the treatment of relapsed/refractory malignant tumors in children.

Timeline

Start

2020-09-27

Primary completion

2021-01-26

Completion

2021-09-26

Drugs

Indications